Exchange of hepatic glucose-6-phosphate (G6P) and glyceraldehyde-3-phosphate via transaldolase modifies hepatic G6P enrichment from glucose or gluconeogenic tracers. Transaldolase exchange was quantified in five healthy, fed subjects following an oral bolus of [1,2,3-13 C 3 ]glycerol (25-30 mg/kg) and paracetamol (10 -12 mg/kg). 13 Hepatic glucose-6-phosphate (G6P) lies at the metabolic crossroads of hepatic glucose and glycogen metabolism. Under fasting conditions when the liver is a net producer of glucose, hepatic G6P is generated by the hydrolysis of glycogen and from gluconeogenesis and is then converted to glucose via G6P. Under fed conditions there is net hepatic glycogen synthesis from both glucose and from gluconeogenic precursors. These metabolic pathways converge at G6P and the hexose carbon skeletons are then incorporated into glycogen via glucose-1-phosphate and UDP-glucose. The gluconeogenic contribution to G6P synthesis is modified in a variety of human diseases, including insulin-and noninsulin-dependent diabetes, cirrhosis, and malaria (1-4). Therefore, quantifying the fraction of G6P derived from gluconeogenesis is a key parameter for defining hepatic carbohydrate metabolism under these and other pathophysiological conditions. In humans, several different tracer methods have been developed for quantifying the contribution of gluconeogenesis to hepatic G6P flux. Hepatic G6P enrichment from these tracers can be quantified noninvasively by analysis of urinary glucuronide enrichment (5-7).
Hepatic glucose-6-phosphate (G6P) lies at the metabolic crossroads of hepatic glucose and glycogen metabolism. Under fasting conditions when the liver is a net producer of glucose, hepatic G6P is generated by the hydrolysis of glycogen and from gluconeogenesis and is then converted to glucose via G6P. Under fed conditions there is net hepatic glycogen synthesis from both glucose and from gluconeogenic precursors. These metabolic pathways converge at G6P and the hexose carbon skeletons are then incorporated into glycogen via glucose-1-phosphate and UDP-glucose. The gluconeogenic contribution to G6P synthesis is modified in a variety of human diseases, including insulin-and noninsulin-dependent diabetes, cirrhosis, and malaria (1) (2) (3) (4) . Therefore, quantifying the fraction of G6P derived from gluconeogenesis is a key parameter for defining hepatic carbohydrate metabolism under these and other pathophysiological conditions. In humans, several different tracer methods have been developed for quantifying the contribution of gluconeogenesis to hepatic G6P flux. Hepatic G6P enrichment from these tracers can be quantified noninvasively by analysis of urinary glucuronide enrichment (5) (6) (7) .
Implicit in all measurements of hepatic gluconeogenesis using labeled gluconeogenic substrates is the assumption that G6P molecules derived from non-gluconeogenic precursors (i.e., glycogenolysis) are not labeled with the tracer. 1 Likewise, when labeled glucose is used to determine the contribution of direct and indirect pathways of hepatic glycogen synthesis under fed conditions, dilution of the glucose tracer at the level of hepatic G6P is assumed to be entirely due to gluconeogenic G6P production.
The possibility that transaldolase (TA) exchange could invalidate these assumptions was recognized by Landau and co-workers (8 -10) . TA catalyzes the exchange between the glyceraldehyde-3-phosphate (GA3P) moiety (i.e., carbons 4, 5, and 6) of fructose-6-phosphate (F6P) and free GA3P in many tissues (11) (12) (13) . This exchange is independent of oxidative pentose phosphate pathway (PPP) flux, hence tissues that have relatively low oxidative PPP utilization of G6P, such as liver, may nevertheless have significant TA exchange activity (13) . Since G6P and F6P are in rapid exchange, G6P molecules derived from glucose or glycogen are exposed to TA activity. With gluconeogenic tracers that label GA3P, the effect of TA exchange is to transfer the label to G6P molecules derived from glucose or glycogen. Hence, the gluconeogenic contribution is overestimated relative to the contribution from glucose or glycogen. Under fed conditions, when the contribution of glucose via the direct pathway to G6P synthesis is quantified with a tracer such as H]glucose, TA exchange depletes the amount of H]G6P resulting in an underestimate of the direct pathway fraction and a corresponding overestimate of the gluconeogenic (indirect) pathway contribution to G6P flux (10) .
The extent of TA activity in human liver during either the fed or fasting state is not known. We present new observations of glucuronide 13 C-isotopomer distributions that are best explained by the presence of TA exchange. We developed a metabolic model that relates the 13 C-isotopomer distributions of glucuronide to TA exchange. Following ingestion of [1,2,3-13 C 3 ]glycerol, human glucuronide 13 C-isotopomer distributions were quantified by 13 C NMR and the extent of TA exchange for the hepatic G6P pool was estimated. Our results indicate that a substantial fraction of hepatic G6P undergoes TA exchange in healthy, fed humans. Failure to account for this activity could result in a significant overestimation of the indirect pathway contribution to hepatic glycogen synthesis with some commonly used tracers of human hepatic carbohydrate metabolism.
MATERIALS AND METHODS

Human Studies
Human studies were performed according to study protocols approved by the Ethics Committees of the University and Pediatrics Hospitals of Coimbra after informed consent was obtained from the subjects. Five healthy nonobese subjects (1 male, 4 females; 20 Ϯ 4 years; 53 Ϯ 13 kg) were studied. After an overnight fast, at 08:00, 11:00, and 14:00 subjects ingested 1 g/kg body weight of cornstarch as an aqueous slurry. Paracetamol (10 -12 mg/kg) was also ingested at 11:00 and the cornstarch meal at 14:00 was accompanied by phenylbutyric acid (5 mg/kg) and [1,2,3-13 C 3 ]glycerol (25-30 mg/kg). Blood (10 mL) was collected at 17:00 and urine was collected from 16:45-18:45.
Sample Processing
Urine was concentrated to 10% of its original volume and this portion was mixed with 9 volumes of 100% ethanol. The precipitate was centrifuged, the supernatant was evaporated to Ϸ10 mL, and the pH was adjusted to 8.0 -9.0 with 1 M NaOH. The supernatant was applied to a 18 ϫ 1 cm diameter Dowex-1X8-200-acetate column. The column was washed with 35 mL of water, the glucuronide eluted with 35 mL of 10 M acetic acid, and the acetic acid fraction was evaporated to dryness at 40 -50°C. The residue was resuspended in 50 mL water and the pH was adjusted to 4.5-5.0.
Paracetamol glucuronide in this solution was derivatized to monoacetoneglucuronic lactone (MAGL) as previously described (14) . Two thousand units of ␤-glucuronidase (H. Pomatia, Sigma Chemical, St. Louis, MO) were added and the solution was incubated at 45°C for 48 hr. The solution was then passed through 10 mL Dowex-50X8-200 H ϩ ion-exchange resin and evaporated to complete dryness at 40°C, resulting in the conversion of free glucuronic acid to glucuronolactone. The lactone was converted to MAGL by stirring for 24 hr with 5 mL of anhydrous acetone and 0.1 mL concentrated H 2 SO 4 . The yellow solution was mixed with 5 mL water, the pH adjusted to between 4 and 5 with 0.5 M Na 2 CO 3 , and the solution evaporated to dryness at room temperature. MAGL was extracted from the salt products with 2-3 mL acetonitrile. For 13 C NMR analysis the acetonitrile supernatant was evaporated to dryness and the residue was resuspended in 0.6 mL of 20% deuterated acetonitrile.
NMR Spectroscopy
Proton-decoupled 13 C NMR spectra were obtained with an 11.75T Varian Unity spectrometer equipped with a 5-mm broadband probe. Spectra were acquired with a 60°pulse angle, an acquisition time of 2.5 sec, a sweep width of 25 kHz, and a pulse delay of 0.5 sec. The number of acquisitions ranged from 8,000 -20,000 (6.7-16.7 hr). The summed free induction decays were processed with 0.1-0.2 Hz line broadening. All NMR spectra were analyzed using the curve-fitting routine supplied with the NUTS PC-based NMR spectral analysis program (Acorn NMR, Fremont CA). 13 C chemical shifts were referenced to the methyl carbon of nondeuterated acetonitrile at 0.3 ppm.
Metabolic Model
The metabolic model relating the formation of G6P 13 Cisotopomers from 13 C-triose phosphate precursors to metabolic exchange and dilution parameters is shown in Fig.  1 . The model assumes negligible flux through the oxida- tive branch of the PPP (15) . The equations shown are specific to 13 C-isotopomers generated from the metabolism of [1,2,3-13 C 3 ]glycerol but they can be applied to glucuronide 13 C-isotopomers from other gluconeogenic 13 C-tracers such as [1,2,3-13 C 3 ]propionate or [3-13 C]lactate, or to glucuronide specific activity measurements from 14 C-gluconeogenic tracers. By formally redefining the source of unlabeled G6P as glycogen instead of glucose, the model can be applied to the fasted state. As illustrated in Fig. 1 , [1,2,3-13 C 3 ]glycerol can be converted to G6P via a relatively direct pathway that involves entry into the triose phosphate pool to form [1,2,3-13 C 3 ]triose P followed by the synthesis of [1,2,3-13 C 3 ] or [4,5,6-13 C 3 ]hexose P via the aldolase reaction. At low enrichment levels (Ͻ5%), the probability of forming hexose P from two [1,2,3-13 C 3 ]triose P molecules is negligible. [1,2,3-13 C 3 ]Glycerol can also converted to G6P by an indirect route that involves the conversion of triose-P to pyruvate followed by the anaplerotic resynthesis of triose-P via pyruvate carboxylase and PEP carboxykinase. As a result of label randomization and pyruvate recycling via the Krebs cycle, the principal product of this indirect pathway is [2,3- ]GA3P. The isotopomers are assumed to be derived from a common pool of hepatic triose phosphates. The formation of G6P isotopomers from these two precursors are described by the following equations:
where: f glucose ϭ fraction of G6P directly derived from glucose; f glycerol ϭ fraction of dihydroxyacetone phosphate derived from glycerol-3-phosphate; TPI ϭ fraction of triose phosphate molecules that underwent triose phosphate isomerase exchange; TA ϭ fraction of G6P molecules that underwent transaldolase exchange; G3P ϭ glycerol-3-phosphate; 3-PGA ϭ 3-phosphoglyceric acid. The equations can be rearranged to relate the metabolic parameters to G6P isotopomer ratios:
When exchange of GA3P with dihydroxyacetone phosphate (DHAP) is complete (TPI ϭ 1.0), the two isotopomer ratios become equivalent and the equation simplifies as follows:
Hepatic G6P 13 C-isotopomer enrichments were quantified from the 13 C NMR multiplet signals of urinary glucuronide after derivatization to MAGL. 13 C-Enrichment of carbon 2 and the percent abundance of the [1,2,3-13 C 3 ]-and [1,2-13 C 2 ]isotopomers were determined from the carbon 2 multiplet of MAGL. As illustrated by Fig. 2 , the multiplet component includes a central singlet signal (S), a quartet arising from 13 C-13 C coupling of carbon 2 with both carbons 1 and 3 (Q), and a doublet due to 13 C-13 C-coupling between carbons 1 and 2 (D). The contribution of each component is expressed as a fraction of the total multiplet area, arbitrarily given a value of 1.0. The singlet fraction (S) is assumed to be derived from natural abundance 13 C and is assigned an enrichment value of 1.11%. For all MAGL spectra this was confirmed by comparing the C2 and C5 singlet areas with those of the natural abundance MAGL methyl signals. In each case the singlet area was within 4% of the theoretical value (obtained from a human MAGL preparation where no 13 C-tracer was given). The Q and D components represent the contributions of [1,2,3-13 C 3 ]-and [1,2-13 C 2 ]G6P, respectively. On this basis the carbon 2 13 C-enrichment and isotopomer abundances were calculated as follows.
Total carbon 2 enrichment (%) ϭ 1/S ϫ 1.11
Excess carbon 2 enrichment (%) The difference in isotopomer enrichment levels between carbons 1, 2, 3 and 4, 5, 6 of glucuronide were analyzed by the paired 2-tailed Student's t-test. Differences were considered significant at P Ͻ 0.05.
RESULTS
Model Predictions
The metabolic model relates TA and TPI exchanges to the 13 C-isotopomer enrichment of the G3P triose moieties from 13 C-enriched gluconeogenic precursors. These precursors can enter the triose phosphate isomerase reaction as DHAP (i.e., 13 C-glycerol) or as GA3P (i.e., 13 C-lactate). When TPI exchange is incomplete the triose halves of G6P are enriched to unequal levels from either precursor substrate. With tracers that enter as DHAP (for example [1,2,3-13 C 3 ]glycerol), carbons 1, 2, and 3 of G6P will have higher 13 C-enrichment than carbons 4, 5, and 6. With gluconeogenic tracers that enter as GA3P prior to TPI exchange (i.e., 13 C-lactate), the G6P enrichment pattern is reversed, with carbons 4, 5, and 6 being more enriched than carbons 1, 2, and 3. Under postabsorptive and fed conditions, the contribution of glycerol carbons to total gluconeogenic flux is small (5-10%). Therefore, for the simulated data shown in Table 1 we assumed that 10% of DHAP flux was derived from glycerol-3-P. Under these conditions, the effect of incomplete TPI exchange on the inequality of 13 C-enrichment between the triose halves of G6P is relatively minor with enriched GA3P precursors. In this study, GA3P is enriched from the indirect metabolism of [1,2,3-13C3]glycerol and is represented by [1, 2] -and [5,6-13C2]G6P. However, other tracers that are metabolized via the Krebs cycle, such as 13C-lactate, will also generate 13C-enriched GA3P. For example, when TPI exchange is 80% complete the difference in 13 C-enrichment levels between the triose moieties of G6P is only 2% (see Table 1 ). However, for DHAP precursors the 13 C-enrichment distribution between the triose halves of G6P is far more sensitive to the level of TPI exchange. As shown in Table 1 , a TPI exchange that is 80% complete results in a 50% higher 13 C-enrichment in the 1,2,3-triose compared to the 4,5,6-triose moiety of G6P. The addition of unlabeled G6P from glucose will systematically dilute the 13 C-enrichment levels but it has no effect on the relative 13 C-enrichments of the G6P triose halves. When TPI exchange is complete the triose halves of G6P are equivalently enriched regardless of the 13 C-tracer source.
TA exchange modifies the 13 C-enrichment distribution by exchanging an unlabeled carbon 4, 5, 6-moiety of F6P with 13 C-enriched GA3P. Therefore, regardless of whether the tracer originated via GA3P or DHAP, the effect of TA exchange is to increase the enrichment in carbons 4, 5, and 6 of G6P relative to carbons 1, 2, and 3. For a given level of TA activity, the inequality between the 13 C-enrichment of the G6P triose halves becomes greater as the fraction of G6P derived from unlabeled hexose sources (f glucose ) is increased.
Experimental Data
The MAGL derivative of urinary paracetamol glucuronide provided high-resolution 13 C NMR spectra of the carbon 2 and 5 13 C-isotopomer signals of the glucuronide moiety (14) , as illustrated by the examples shown in Fig. 2 Table  2 ) but is consistent with TA activity. The 13 C NMR signals of [1,2-13 C 2 ]-and [5,6-13 C 2 ]glucuronide, which represent triose phosphate 13 C-isotopomers derived via PEP and the Krebs cycle, were also well resolved in the spectra, albeit with low intensities. The observation of corresponding [2, [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C 2 ]glutamine 13 C-isotopomer signals from urinary phenylacetylglutamine obtained from each subject is con- As indicated by the simulated data of Table 1 , the concordance of these isotopomer ratios is consistent with TPI exchange being Ϸ99% complete. Under these conditions the simplified equation (Eq. [7] ) can provide reasonable estimates of TA exchange from the glucuronide 13 C-isotopomer ratios for a given fraction of direct pathway contribution (f glucose ) to G6P synthesis. For healthy subjects under fed conditions, 50 -70% of hepatic G6P is derived directly from glucose (7, 10, 18) . Assuming a direct pathway contribution of 60%, the fraction of G6P undergoing TA exchange was estimated for each subject, as shown in Table 3 . In addition, we calculated the apparent direct and indirect pathway contributions that would be estimated with glucose tracers that are diluted by TA exchange ([6-14 C]-and [5-3 H]glucose).
The data indicate that for three of the subjects the extent of TA exchange and its effects on direct and indirect pathway estimates was relatively small. However, the remaining two subjects had substantial TA exchange activities, resulting in a sizeable overestimation of the indirect pathway contribution to UDP-glucose synthesis. As shown by the examples in Fig. 2 , the smaller intensity of the carbon 2 multiplets relative to those of carbon 5 is quite sensitive to the fraction of G6P undergoing TA activity. The unequal intensities of the carbon 2 and 5 multiplets were also accompanied by similar differences between the multiplets of glucuronide carbons 3 and 4 (data not shown). 3 
DISCUSSION
The labeling distribution of glucuronide from gluconeogenic tracers is influenced by both TPI and TA exchanges.
Depending on the source of the gluconeogenic tracer, the effect of incomplete TPI exchange on the 13 C-enrichment distribution between the triose halves can either augment or oppose that of TA. Therefore, in order to evaluate the extent of TA activity the contribution of incomplete TPI exchange to the enrichment distribution of glucuronide has to be considered. In humans the formation of glucuronide or glucose with unequal labeling of the triose halves have been reported with several different 13 C-and 14 C-gluconeogenic tracers (19 -21) . Most of these measurements were obtained after extended fasting when the fraction of G6P derived from glycogenolysis is small. Under these conditions the glucuronide or glucose labeling distribution is insensitive to TA activity but it is influenced by incomplete TPI exchange. The distribution of radioactivity from [2-14 C]glycerol and [1-14 C]lactate in the triose halves of glucuronide was quantified in 36-hr fasted humans (20) . The specific activity from [2-14 C]glycerol was Ϸ20% higher in C2 compared to C5 of glucuronide, while the specific activity from [1-14 C]lactate was Ϸ10% higher in C4 compared to C3. These observations are consistent with hepatic TPI exchange being Ϸ90% complete. In individuals that were fasted for 60 hr and infused with 14 C-propionate or 14 C-acetate, there was essentially equal distribution of label between the triose moieties of plasma glucose, indicating near complete TPI exchange (8, 21) . However, when [3-14 C]lactate was infused under fed conditions the specific activities of carbons 5 and 6 of glucose were 1.4 -1.6 times greater than those of carbons 1 and 2 and this was attributed to a combination of TA activity and incomplete TPI exchange (8) . In light of our current findings and the previously cited reports of near complete TPI exchange in human liver, we conclude that the unequal specific activity distributions in the triose halves of glucose reported by Magnusson et al. (8) are largely attributable to TA exchange. We applied the specific activity ratios of glucose carbon 1 to carbon 6 and carbon 2 to carbon 5 to our model using the same assumptions as for our 13 C-isotopomer data (i.e., 60% direct pathway contribution and complete TPI exchange). This analysis revealed that in the study of Magnusson et al. 33% of hepatic G6P had participated in TA exchange.
The isotopomer analysis relies on the assumption that flux through the oxidative portion of the PPP is negligible (7), the fraction of G6P derived from the indirect pathway is quantified as the ratio of glucuronide hydrogen 5 enrichment relative to that of body water. TA activity contributes to the enrichment of TA was solved from Eq. [7] using the mean C2 and C5 isotopomer ratios and assuming a direct pathway fraction of 60% (f glucose ϭ 0.6) and indirect pathway fraction of 40%. Triose phosphate isomerase exchange is assumed to be complete (TPI ϭ hydrogen 5, resulting in an overestimate of the indirect pathway fraction (7) . In summary, transaldolase exchange is active in human liver and it may result in significant overestimates of hepatic gluconeogenic activity with 2 H 2 O, gluconeogenic carbon tracers, or certain glucose tracers at least in the fed state. Our data indicate that the unequal enrichment of the triose moieties of G6P from 13 C gluconeogenic tracers is almost entirely attributable to transaldolase activity and that transaldolase exchange can be quantified from the relative 13 C-enrichments of the G6P triose halves. With gluconeogenic carbon tracers such as 13 C-glycerol or 13 Clactate, this information is inherent in the 13 C-enrichment distribution of plasma glucose or urinary glucuronide, and hence in principle it could be used to correct for transaldolase activity.
